NCT05797428 The Effects of Logotherapy in Adolescents With Mood Disorders
| NCT ID | NCT05797428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Mood Disorder of Depressed Type |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-05-19 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-05-19 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Logotherapy can help people find their meaning in life and help people reduce their suicidal ideation. Suicide was the second leading cause of death for 15-24 year-olds. Logotherapy can increase exploration of meaning in life for adolescents and prevent them from attempting suicide. However, most research only explored the effects of logotherapy on meaning in life and depression in adolescents with mood disorders. There is a lack of research to explore the effects of logotherapy on anxiety and suicidal ideation in adolescents. Therefore, this study will explore the effects of logotherapy on meaning in life, depression, anxiety and suicidal ideation in adolescents with mood disorders. This study will carry on for two years and the sample will be recruited from the adolescents' outpatient clinic of psychiatric department in hospitals. The first and second year of the study will use a single-blind randomized controlled trial approach, the aim is to evaluate the short-term and longitudinal effects of logotherapy meaning in life, depression, anxiety and suicidal ideation in adolescents with mood disorders, the sample will collect 120 adolescents with mood disorders, and will use four instruments for testing the logotherapy intervention. The four instruments are: (1) Purpose in life Test, (2) Beck Depression Inventory II, (3) Beck Anxiety Inventory, (4) Beck Scale for Suicide Ideation. Data will be analyzed using the Statistic Package for the Social Science. The result of this study will be applied to the mental health team in the clinical psychiatric department for taking care of patients, and help adolescents with mood disorders to find their meaning in life, further, to reduce their depression, anxiety and suicidal ideation.
Eligibility Criteria
Inclusion Criteria: * Patients with mood disorders (such as depression, bipolar disorder) diagnosed by a psychiatrist. * Patient Health Questionnaire-9 items (PHQ-9) score 5-19 points (indicating mild depression to moderate to severe depression) * Agree to participate in logotherapy * Able to participate in logotherapy Exclusion Criteria: * Patients with severe emotional disorders who cannot participate in logotherapy. * Those who have severe psychopathological phenomena and cannot judge reality or those who are mentally deficient. * Those who have serious suicidal ideation or clear suicide plan are not suitable for interview
Contact & Investigator
Fan-Ko Sun, PhD
STUDY CHAIR
Second Degree Bachelor of Science in nursing, National Taiwan University
Frequently Asked Questions
Who can join the NCT05797428 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 24 Years, studying Mood Disorder of Depressed Type. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05797428 currently recruiting?
Yes, NCT05797428 is actively recruiting participants. Contact the research team at sunfanko@ntu.edu.tw for enrollment information.
Where is the NCT05797428 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT05797428 clinical trial?
NCT05797428 is sponsored by National Taiwan University Hospital. The principal investigator is Fan-Ko Sun, PhD at Second Degree Bachelor of Science in nursing, National Taiwan University. The trial plans to enroll 120 participants.